Luminex-based Assay to Identify Major IgE-binding Episode Among IgE-mediated Wheat-allergic Patient

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

September 13, 2019

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Wheat Allergy
Interventions
PROCEDURE

Blood drawing

Blood drawn will be done once using 15 mL of blood volume (Serum or plasma samples will be collected during the routine follow up of level of sIgE to wheat or during the oral food challenge test which intravenous insertion routinely prepared in case of the emergency reaction occurred). The specimen will be transferred to the Icahn School of Medicine at Mount Sinai, New York, USA for Laboratory processing (Luminex-based peptide assay)

Trial Locations (1)

10700

Siriraj Hospital, Bangkoknoi

All Listed Sponsors
collaborator

Icahn School of Medicine at Mount Sinai

OTHER

collaborator

Samitivej Hospital group

UNKNOWN

lead

Mahidol University

OTHER

NCT04100122 - Luminex-based Assay to Identify Major IgE-binding Episode Among IgE-mediated Wheat-allergic Patient | Biotech Hunter | Biotech Hunter